Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.970
+0.150 (8.24%)
At close: Mar 9, 2026, 4:00 PM EDT
1.999
+0.029 (1.47%)
After-hours: Mar 9, 2026, 7:22 PM EDT
Caribou Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -148.13 | -149.11 | -102.07 | -99.42 | -66.92 | |
| Depreciation & Amortization | 3.65 | 3.93 | 3.53 | 1.62 | 0.98 | |
| Loss (Gain) From Sale of Assets | -0.03 | -0.01 | -0.03 | - | 0 | |
| Asset Writedown & Restructuring Costs | 12.15 | 1.63 | - | 0.6 | 1 | |
| Loss (Gain) From Sale of Investments | -1.04 | -4.62 | -4.42 | -0.66 | 0.05 | |
| Loss (Gain) on Equity Investments | 9.16 | - | - | - | - | |
| Stock-Based Compensation | 12.68 | 16.71 | 13.75 | 11.72 | 3.45 | |
| Other Operating Activities | 1.05 | -1.62 | 3.28 | -0.62 | -0.15 | |
| Change in Accounts Receivable | 0.35 | 0.15 | 0.88 | 0.19 | -1.16 | |
| Change in Accounts Payable | 3.25 | -0.35 | 1.82 | -2.72 | 1.14 | |
| Change in Unearned Revenue | -2.8 | -2.5 | -16.94 | -4.84 | 29.64 | |
| Change in Other Net Operating Assets | -0.74 | -2.4 | 6.75 | 3.26 | -0.87 | |
| Operating Cash Flow | -110.99 | -138.2 | -93.29 | -90.97 | -32.52 | |
| Capital Expenditures | -1.36 | -4.88 | -11.61 | -6.45 | -2.12 | |
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | |
| Sale (Purchase) of Intangibles | - | -1.63 | - | -0.6 | -1 | |
| Investment in Securities | 103.6 | 93.1 | -56.57 | -86.2 | -173.28 | |
| Investing Cash Flow | 102.24 | 86.61 | -68.18 | -93.25 | -176.4 | |
| Long-Term Debt Issued | - | - | - | - | 1.15 | |
| Long-Term Debt Repaid | - | - | - | - | -0.12 | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.03 | |
| Issuance of Common Stock | 4.82 | 16.72 | 154.3 | 2.13 | 323.57 | |
| Financing Cash Flow | 4.82 | 16.72 | 154.3 | 2.13 | 433.43 | |
| Net Cash Flow | -3.93 | -34.87 | -7.18 | -182.08 | 224.51 | |
| Free Cash Flow | -112.35 | -143.08 | -104.9 | -97.42 | -34.64 | |
| Free Cash Flow Margin | -1006.82% | -1431.66% | -304.27% | -703.34% | -360.91% | |
| Free Cash Flow Per Share | -1.20 | -1.58 | -1.42 | -1.60 | -1.09 | |
| Cash Income Tax Paid | - | - | 0.17 | - | 0.01 | |
| Levered Free Cash Flow | -69.8 | -87.71 | -64.36 | -56.11 | -33.46 | |
| Unlevered Free Cash Flow | -69.8 | -87.71 | -64.36 | -56.11 | -33.46 | |
| Change in Working Capital | -0.48 | -5.11 | -7.32 | -4.2 | 29.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.